Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2025-01-23 00:00:00 ET · period of report 2025-01-21 · accession 0001415889-25-001931 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-23 | 2025-01-21 | HRMY | Dayno Jeffrey M. | Pres, CEO, Dir | M - OptEx | $8.22 | +19.3K | 19.3K | New | +$158.6K |
| D | 2025-01-23 | 2025-01-21 | HRMY | Dayno Jeffrey M. | Pres, CEO, Dir | S - Sale+OE | $40.13 | -19.3K | 0 | -100% | -$774.2K |
| DM | 2025-01-23 | 2025-01-21 | HRMY | Dayno Jeffrey M. | Pres, CEO, Dir | M - OptEx | $0.00 | -19.3K | 20.0K | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-21 | M | A | 19,293 | $8.22 | 19,293 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-21 | S | D | 19,293 | $40.13 | 0 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.50. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option | 2025-01-21 | M | D | 9,737 | $0.00 | 2,435 | D | $8.22 · — to 2030-03-04 | 9,737 Common Stock | (F5) The stock option vests in five equal annual installments beginning on March 1, 2021. |
| 4 | Derivative | Stock Option | 2025-01-21 | M | D | 6,086 | $0.00 | 0 | D | $8.22 · — to 2029-01-07 | 6,086 Common Stock | (F4) The stock option vests in five equal annual installments beginning on January 1, 2020. |
| 5 | Derivative | Stock Option | 2025-01-21 | M | D | 3,470 | $0.00 | 20,000 | D | $8.22 · — to 2027-11-13 | 3,470 Common Stock | (F3) The stock option vests in five equal annual installments beginning on November 1, 2018. |